Poised to revolutionize the field of infection prevention through advanced automation, Next Gen Diagnostics (NGD) will expose industry professionals to its pioneering detection system at Becker’s Healthcare Conference. Meticulously designed, NGD’s system remarkably combines robotic sample preparation, automated sequencing, bioinformatics, and efficient detection of bacterial infection transmission, making it possible for hospitals to detect and impede infection transmission in real time. The system is not only efficient but also cost-effective, putting it within the reach of countless healthcare facilities.
Advancements in infection control science make it apparent that real-time bacterial sequencing is critical to uncovering the vast majority of infection transmissions within hospital settings. Responding to this need, the new NGD200 plays a vital role in lysis, extraction, normalization, library construction, pooling, and size selection—enabling the creation of 48 bacterial sequence-ready libraries without needing extensive technical skills.
Accompanying this system is NGD’s HIPAA-compliant EpiAssist platform, which uses sophisticated, automated bioinformatics to provide intuitive and informative displays of ward overlays, procedures, and caregiver overlaps. With this streamlined presentation of critical information, infection prevention (IP) teams can seamlessly identify root causes and deploy interventions effectively.
With patient safety at the core of its mission, NGD’s CEO and Founder, Dr. Paul A. Rhodes, expressed enthusiasm about showcasing a concrete solution for infection prevention. Such a solution, he shared, has the potential to curtail long-term hospital stays and curb the spread of hospital-acquired infections.
Infection prevention professionals can catch a glimpse of this promising new-age detection system at Booth #115. NGD’s offering doesn’t stop there; the company provides complete installation, minimal training (thanks to the low-skill requirements of the system), and continuous technical support, stacking up as a comprehensive, turnkey service.
About NGD and its commitment to real-time infection prevention, their solution comprises a fully-automated complete whole-genome sequencing platform and a bioinformatics pipeline. Headquartered in Cambridge, MA, with a branch in Israel, the company’s NGD200 system and NGD EpiAssist provide a low-cost solution for broad adoption to help deliver real-time detection and prevent infection transmission in hospitals.